Overview

7 Days vs. 14 Days of Vonoprazan-based Triple Therapy for H. Pylori Eradication

Status:
COMPLETED
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
The study aims to test the efficacy of 7 days vs. 14 days of Vonoprazan-triple therapy in the eradication of Helicobacter Pylori infection in adolescents and young children.
Phase:
PHASE3
Details
Lead Sponsor:
Alexandria University
Treatments:
1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine
Amoxicillin
Clarithromycin